Calidi Biotherapeutics Stock Technical Analysis
| CLDI Stock | 1.03 0.03 3.00% |
As of the 29th of January, Calidi Biotherapeutics shows the Standard Deviation of 3.77, mean deviation of 2.73, and Risk Adjusted Performance of (0.09). Calidi Biotherapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Calidi Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Calidi, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CalidiCalidi Biotherapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Calidi Biotherapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 120.0 | Strong Buy | 1 | Odds |
Most Calidi analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Calidi stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Calidi Biotherapeutics, talking to its executives and customers, or listening to Calidi conference calls.
Is there potential for Biotechnology market expansion? Will Calidi introduce new products? Factors like these will boost the valuation of Calidi Biotherapeutics. Projected growth potential of Calidi fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Calidi Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Calidi Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Calidi's accounting equity. The concept of intrinsic value—what Calidi Biotherapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Calidi Biotherapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Calidi Biotherapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Calidi Biotherapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Calidi Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Calidi Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Calidi Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Calidi Biotherapeutics.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Calidi Biotherapeutics on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Calidi Biotherapeutics or generate 0.0% return on investment in Calidi Biotherapeutics over 90 days. Calidi Biotherapeutics is related to or competes with Clearmind Medicine, Can Fite, Kazia Therapeutics, Silo Pharma, CNS Pharmaceuticals, 60 Degrees, and Xenetic Biosciences. Calidi Biotherapeutics is entity of United States More
Calidi Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Calidi Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Calidi Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 24.52 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 4.9 |
Calidi Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Calidi Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Calidi Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Calidi Biotherapeutics historical prices to predict the future Calidi Biotherapeutics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (1.02) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Calidi Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Calidi Biotherapeutics January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.01) | |||
| Mean Deviation | 2.73 | |||
| Coefficient Of Variation | (729.93) | |||
| Standard Deviation | 3.77 | |||
| Variance | 14.23 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (1.02) | |||
| Maximum Drawdown | 24.52 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 4.9 | |||
| Skewness | (0.29) | |||
| Kurtosis | 2.33 |
Calidi Biotherapeutics Backtested Returns
Calidi Biotherapeutics secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of risk over the last 3 months. Calidi Biotherapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Calidi Biotherapeutics' Mean Deviation of 2.73, risk adjusted performance of (0.09), and Standard Deviation of 3.77 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Calidi Biotherapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Calidi Biotherapeutics is expected to be smaller as well. At this point, Calidi Biotherapeutics has a negative expected return of -0.58%. Please make sure to confirm Calidi Biotherapeutics' treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Calidi Biotherapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.19 |
Very weak predictability
Calidi Biotherapeutics has very weak predictability. Overlapping area represents the amount of predictability between Calidi Biotherapeutics time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Calidi Biotherapeutics price movement. The serial correlation of 0.19 indicates that over 19.0% of current Calidi Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Calidi Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Calidi Biotherapeutics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Calidi Biotherapeutics across different markets.
About Calidi Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Calidi Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Calidi Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Calidi Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Calidi Biotherapeutics. By analyzing Calidi Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Calidi Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Calidi Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.18 | 0.16 | 0.14 | Price To Sales Ratio | 625.63 | 1.7K | 1.0K |
Calidi Biotherapeutics January 29, 2026 Technical Indicators
Most technical analysis of Calidi help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Calidi from various momentum indicators to cycle indicators. When you analyze Calidi charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.01) | |||
| Mean Deviation | 2.73 | |||
| Coefficient Of Variation | (729.93) | |||
| Standard Deviation | 3.77 | |||
| Variance | 14.23 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (1.02) | |||
| Maximum Drawdown | 24.52 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 4.9 | |||
| Skewness | (0.29) | |||
| Kurtosis | 2.33 |
Calidi Biotherapeutics January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Calidi stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 1.02 | ||
| Day Typical Price | 1.02 | ||
| Price Action Indicator | 0.03 | ||
| Market Facilitation Index | 0.03 |
Complementary Tools for Calidi Stock analysis
When running Calidi Biotherapeutics' price analysis, check to measure Calidi Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calidi Biotherapeutics is operating at the current time. Most of Calidi Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Calidi Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calidi Biotherapeutics' price. Additionally, you may evaluate how the addition of Calidi Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |